Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy

Head and Neck

Volumn 31, Issue 8, 2009, Pages 1013-1021

  Cohen, Ezra E W ^a,b   Baru, Joshua ^c   Huo, Dezheng ^a   Haraf, Daniel J ^d   Crowley, Maureen ^a   Witt, Mary Ellyn ^d   Blair, Elizabeth A ^a,b   Weichselbaum, Ralph R ^d   Rosen, Fred ^c   Vokes, Everett E ^a,b,d   Stenson, Kerstin ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Chicago   (United States)

^c Jr Hospital of Cook County   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Bone involvement; Chemoradiotherapy; Oral cavity; Osteoradionecrosis; T4

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA; PACLITAXEL;

ARTERY RUPTURE; ARTICLE; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CAROTID ARTERY; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG EFFICACY; ESOPHAGUS STRICTURE; HUMAN; MOUTH CANCER; NECK INJURY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION RESPONSE; SKIN FISTULA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 67650448068     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21062     Document Type: Article

References (27)

1. Hinerman RW, Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB. Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck 2004;26:984-994. (Pubitemid 39488127)
2. Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity. Int J Radiat Oncol Biol Phys 1997;39:137-148. (Pubitemid 27396290)
3. Rodgers LW Jr, Stringer SP, Mendenhall WM, Parsons JT, Cassisi NJ, Million RR. Management of squamous cell carcinoma of the floor of mouth. Head Neck 1993; 15:16-19. (Pubitemid 23003467)
4. Sessions DG, Spector GJ, Lenox J, Haughey B, Chao C, Marks J. Analysis of treatment results for oral tongue cancer. Laryngoscope 2002;112:616-625. (Pubitemid 34285925)
5. Sessions DG, Spector GJ, Lenox J, et al. Analysis of treatment results for floor-of-mouth cancer. Laryngoscope 2000;110(10 Part 1):1764-1772. (Pubitemid 30764261)
6. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349: 2091-2098. (Pubitemid 37464533)
7. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 2005;27:843-850.
8. Cohen EE, Lingen MW, Vokes EE. The expanding role of systemic therapy in head and neck cancer. J Clin Oncol 2004;22:1743-1752. (Pubitemid 41079815)
9. Cohen EE, Haraf DJ, List MA, et al. High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial. J Clin Oncol 2006;24:3438-3444. (Pubitemid 46638901)
10. Haraf DJ, Rosen FR, Stenson K, et al. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Clin Cancer Res 2003;9(16 Part 1):5936-5943. (Pubitemid 38018079)
11. Kies MS, Haraf DJ, Rosen F, et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 2001;19:1961-1969. (Pubitemid 32702540)
12. Rosen FR, Haraf DJ, Kies MS, et al. Multicenter randomized phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer. Clin Cancer Res 2003; 9:1689-1697. (Pubitemid 36554592)
13. Vokes EE, Kies MS, Haraf DJ, et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 2000; 18:1652-1661. (Pubitemid 30220543)
14. Vokes EE, Stenson K, Rosen FR, et al. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 2003;21:320-326. (Pubitemid 46606162)
15. Liao CT, Chang JT, Wang HM, et al. Surgical outcome of T4a and resected T4b oral cavity cancer. Cancer 2006; 107:337-344. (Pubitemid 44036563)
16. Diaz EM Jr, Holsinger FC, Zuniga ER, Roberts DB, Sorensen DM. Squamous cell carcinoma of the buccal mucosa: one institution's experience with 119 previously untreated patients. Head Neck 2003;25:267-273. (Pubitemid 36368677)
17. Erkal HS, Serin M, Amdur RJ, Villaret DB, Stringer SP, Mendenhall WM. Squamous cell carcinomas of the soft palate treated with radiation therapy alone or followed by planned neck dissection. Int J Radiat Oncol Biol Phys 2001;50:359-366. (Pubitemid 32472264)
18. Lapeyre M, Bollet MA, Racadot S, et al. Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins. Head Neck 2004;26:216-223. (Pubitemid 38292731)
19. Smith RV, Krevitt L, Yi SM, Beitler JJ. Early wound complications in advanced head and neck cancer treated with surgery and Ir 192 brachytherapy. Laryngoscope 2000;110:8-12. (Pubitemid 30046637)
20. Turner SL, Slevin NJ, Gupta NK, Swindell R. Radical external beam radiotherapy for 333 squamous carcinomas of the oral cavity-evaluation of late morbidity and a watch policy for the clinically negative neck. Radiother Oncol 1996;41:21-29. (Pubitemid 26396293)
21. Wang ZH, Zhang ZY, Mendenhall WM. Postoperative radiotherapy after titanium plate mandibular reconstruction for oral cavity cancer. Am J Clin Oncol 2005;28:460-463. (Pubitemid 41437384)
22. Costantino PD, Friedman CD, Steinberg MJ. Irradiated bone and its management. Otolaryngol Clin North Am 1995;28:1021-1038.
23. Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 1983;41:283-288.
24. Buchbinder D, St. Hilaire H. The use of free tissue transfer in advanced osteoradionecrosis of the mandible. J Oral Maxillofac Surg 2006;64:961-964. (Pubitemid 43744355)
25. Sciubba JJ, Goldenberg D. Oral complications of radiotherapy. Lancet Oncol 2006;7:175-183.
26. Deutsch M, Kroll SS, Ainsle N, Wang B. Influence of radiation on late complications in patients with free fibular flaps for mandibular reconstruction. Ann Plast Surg 1999;42:662-664. (Pubitemid 29262738)
27. Gal TJ, Yueh B, Futran ND. Influence of prior hyperbaric oxygen therapy in complications following microvascular reconstruction for advanced osteoradionecrosis. Arch Otolaryngol Head Neck Surg 2003;129:72-76. (Pubitemid 36074942)